{"pmid":32374009,"title":"Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.","text":["Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19.","Eur Rev Med Pharmacol Sci","Valdenassi, L","Franzini, M","Ricevuti, G","Rinaldi, L","Galoforo, A C","Tirelli, U","32374009"],"journal":"Eur Rev Med Pharmacol Sci","authors":["Valdenassi, L","Franzini, M","Ricevuti, G","Rinaldi, L","Galoforo, A C","Tirelli, U"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32374009","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.26355/eurrev_202004_20976","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138496357629954,"score":9.490897,"similar":[{"pmid":32462858,"title":"Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.","text":["Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.","The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.","J Biol Regul Homeost Agents","Marini, S","Maggiorotti, M","Dardes, N","Bonetti, M","Martinelli, M","Re, L","Carinci, F","Tavera, C","32462858"],"abstract":["The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially."],"journal":"J Biol Regul Homeost Agents","authors":["Marini, S","Maggiorotti, M","Dardes, N","Bonetti, M","Martinelli, M","Re, L","Carinci, F","Tavera, C"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462858","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.23812/20-250-E-56","keywords":["covid-19","sars-cov-2","clinical study","oxygen-ozone","protocol"],"e_drugs":["Ozone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521519108096,"score":61.593796},{"pmid":32384798,"title":"Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.","text":["Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.","(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-kappa B/Nrf2 pathways and IL-6/IL-1beta expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-kappa B/Nrf2 balance and IL-6 and IL-1beta expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed.","Antioxidants (Basel)","Martinez-Sanchez, Gregorio","Schwartz, Adriana","Donna, Vincenzo Di","32384798"],"abstract":["(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-kappa B/Nrf2 pathways and IL-6/IL-1beta expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-kappa B/Nrf2 balance and IL-6 and IL-1beta expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed."],"journal":"Antioxidants (Basel)","authors":["Martinez-Sanchez, Gregorio","Schwartz, Adriana","Donna, Vincenzo Di"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32384798","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3390/antiox9050389","keywords":["keap1/nrf2/are pathway","nf-kappa b","nrf2","sars-cov-2","ozone therapy 1"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ozone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666340102023938048,"score":59.79244},{"pmid":32437014,"title":"A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.","text":["A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.","Currently, coronavirus disease 2019 (COVID-19) is a global pandemic disease with significant morbidity and mortality. Ozone may exert its antiviral actions and ozone therapy has been demonstrated therapeutically usefulness in influenza and novel viruses. In this letter, two severe cases with COVID-19 received ozone therapy were described. The results showed that ozone therapy may promote recovery of clinical condition and improvement of chest CT images, shorten the duration of viral shedding and length of hospital stay. This article is protected by copyright. All rights reserved.","J Med Virol","Zheng, Zhishui","Dong, Minglin","Hu, Ke","32437014"],"abstract":["Currently, coronavirus disease 2019 (COVID-19) is a global pandemic disease with significant morbidity and mortality. Ozone may exert its antiviral actions and ozone therapy has been demonstrated therapeutically usefulness in influenza and novel viruses. In this letter, two severe cases with COVID-19 received ozone therapy were described. The results showed that ozone therapy may promote recovery of clinical condition and improvement of chest CT images, shorten the duration of viral shedding and length of hospital stay. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zheng, Zhishui","Dong, Minglin","Hu, Ke"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437014","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26040","keywords":["coronavirus < virus classification","reovirus < virus classification","sars coronavirus < virus classification"],"e_drugs":["Ozone"],"topics":["Treatment"],"weight":1,"_version_":1667521393656332288,"score":47.39942}]}